Similar articles for PMID: 22414636

Year	Number of Results
1997	1
1999	2
2000	3
2001	5
2002	3
2003	6
2004	6
2005	12
2006	8
2007	8
2008	6
2009	7
2010	4
2011	4
2012	3
2013	5
2014	2
2017	6
2018	3
2020	1
2021	3
2022	1
2023	2
2024	0

1

In vivo evaluation of a cancer therapy strategy combining HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy.

Sorensen A, Mairs RJ, Braidwood L, Joyce C, Conner J, Pimlott S, Brown M, Boyd M. Sorensen A, et al. J Nucl Med. 2012 Apr;53(4):647-54. doi: 10.2967/jnumed.111.090886. Epub 2012 Mar 13. J Nucl Med. 2012. PMID: 22414636 Free article.

2

Assessment in vitro of a novel therapeutic strategy for glioma, combining herpes simplex virus HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy.

Quigg M, Mairs RJ, Brown SM, Harland J, Dunn P, Rampling R, Livingstone A, Wilson L, Boyd M. Quigg M, et al. Med Chem. 2005 Sep;1(5):423-9. doi: 10.2174/1573406054864124. Med Chem. 2005. PMID: 16787326

3

A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivo.

Mairs RJ, Ross SC, McCluskey AG, Boyd M. Mairs RJ, et al. J Nucl Med. 2007 Sep;48(9):1519-26. doi: 10.2967/jnumed.107.042226. Epub 2007 Aug 17. J Nucl Med. 2007. PMID: 17704246 Free article.

4

Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill.

Boyd M, Mairs RJ, Mairs SC, Wilson L, Livingstone A, Cunningham SH, Brown MM, Quigg M, Keith WN. Boyd M, et al. Oncogene. 2001 Nov 22;20(53):7804-8. doi: 10.1038/sj.onc.1204955. Oncogene. 2001. PMID: 11753659

5

A gene therapy/targeted radiotherapy strategy for radiation cell kill by.

Boyd M, Mairs RJ, Cunningham SH, Mairs SC, McCluskey A, Livingstone A, Stevenson K, Brown MM, Wilson L, Carlin S, Wheldon TE. Boyd M, et al. J Gene Med. 2001 Mar-Apr;3(2):165-72. doi: 10.1002/1521-2254(2000)9999:9999<::AID-JGM158>3.0.CO;2-C. J Gene Med. 2001. PMID: 11318115

6

Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.

Ishida D, Nawa A, Tanino T, Goshima F, Luo CH, Iwaki M, Kajiyama H, Shibata K, Yamamoto E, Ino K, Tsurumi T, Nishiyama Y, Kikkawa F. Ishida D, et al. Cancer Lett. 2010 Feb 1;288(1):17-27. doi: 10.1016/j.canlet.2009.06.014. Epub 2009 Jul 14. Cancer Lett. 2010. PMID: 19604626

7

Expression of inhibitor of growth 4 by HSV1716 improves oncolytic potency and enhances efficacy.

Conner J, Braidwood L. Conner J, et al. Cancer Gene Ther. 2012 Jul;19(7):499-507. doi: 10.1038/cgt.2012.24. Epub 2012 May 18. Cancer Gene Ther. 2012. PMID: 22595793

8

An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects.

Boyd M, Mairs RJ, Keith WN, Ross SC, Welsh P, Akabani G, Owens J, Vaidyanathan G, Carruthers R, Dorrens J, Zalutsky MR. Boyd M, et al. J Gene Med. 2004 Aug;6(8):937-47. doi: 10.1002/jgm.578. J Gene Med. 2004. PMID: 15293352

9

Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine.

Boyd M, Cunningham SH, Brown MM, Mairs RJ, Wheldon TE. Boyd M, et al. Gene Ther. 1999 Jun;6(6):1147-52. doi: 10.1038/sj.gt.3300905. Gene Ther. 1999. PMID: 10455418

10

Application of targeted radiotherapy/gene therapy to bladder cancer cell lines.

Fullerton NE, Mairs RJ, Kirk D, Keith WN, Carruthers R, McCluskey AG, Brown M, Wilson L, Boyd M. Fullerton NE, et al. Eur Urol. 2005 Feb;47(2):250-6. doi: 10.1016/j.eururo.2004.09.009. Eur Urol. 2005. PMID: 15661422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

95 results

Results by year